adult stem cell News

Adult stem cells and regenerative medicine are the future. American CryoStem takes patients one step closer to guaranteeing future health by preserving adult stem cells for personal use.

Two autologous stem cell therapy sessions prevented patient from foot amputation

Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple parts of the body.

The International Cellular Medicine Society (ICMS), a nonprofit organization dedicated to patient safety and education on the medical use of adult stem cells, announces the addition of esteemed bioethicist Glenn McGee, PhD to its Board of Directors.

A stem-cell enhancing product that has been making waves in Australia and New Zealand is now available in Singapore - Colostem®. Endorsed by the non-profit Adult Stem Cell Foundation.

-Electromyogram (EMG) findings show improvement in conduction speed and latency -RNL Bio’s stem cell therapy demonstrates effective outcomes

Patient’s own fat-derived stem cell cured severe atopic syndrome

Korean-FDA approved RNL’s Astrostem based on patient’s own fat derived stem cells to treat spinal cord injury. Phase I human trial will be done by intravenous infusion of stem cells at Sam Hospital in Anyang, South Korea

Dr. Bayer will be responsible for developing pre-clinical and clinical trial protocols for use by research centers conducting pre-clinical and clinical trials using Stemedica adult stem cell products.

Stemedica Cell Technologies, Inc. announces leading stem cell specialist Dr Nabil Dib, MD as Special Advisor to its Board of Directors. Dr Dib is President of the ISCTR and Director of Cardiovascular and Stem Cell Consultants (CSCC).

Starting this April, a clinical trial will test the potential of treating patients suffering from Romberg’s disease at The Asan Medical Center in Seoul, Korea.